Dana-Farber Cancer Institute; Harvard Medical School
Chestnut Hill , Massachusetts
Dr. Otto Metzger is a physician in Medical Oncology at Dana-Farber Cancer Institute and an Assistant Professor in Medicine at Harvard Medical School.
As a clinician and translational researcher, Dr. Metzger integrates innovative research into state-of-the-art compassionate clinical care. Much of his research focuses on the development of novel therapies for patients diagnosed with breast cancer. Dr. Metzger research is also focused on a specific subset of breast cancer named invasive lobular carcinoma. He has multiple publications in this field, with 2669 citations; he has been invited to present her work locally, nationally, and internationally. Dr. Metzger has demonstrated innovation in approaches to the classification of lobular carcinoma as demonstrated by his influential first author publications.
In addition to his roles a clinician and trialist, Dr. Metzger dedicates a significant amount of his time serving as an Executive Officer for the Alliance for Clinical Trials in Oncology. At the Alliance he oversees a large portfolio of phase III studies in the field of breast cancer.
Alliance Foundation Trials (Individual(s) Involved: Self): Consultant; Merck Sharp & Dome (Individual(s) Involved: Self): Consultant; Pfizer (Individual(s) Involved: Self; Clinical Condition: Oncology): Grant/Research Support; Resilience Care (Individual(s) Involved: Self): Consultant; Roche (Individual(s) Involved: Self): Grant/Research Support; Sanofi (Individual(s) Involved: Self; Clinical Condition: Oncology): Grant/Research Support
Wednesday, April 27, 2022
9:00 AM – 10:15 AM
Wednesday, April 27, 2022
9:25 AM – 9:40 AM
Wednesday, April 27, 2022
10:00 AM – 10:15 AM